Related Experiment Video
Updated: Jan 5, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Systemic and breath biomarkers for asthma: an update
Ida Mogensen1,2, Anna James3,4, Andrei Malinovschi1
1Department of Medical Sciences, Clinical Physiology.
Identifying asthma biomarkers is key for personalized treatment. Recent advances focus on type 2 inflammation markers like blood eosinophils and FeNO, aiding risk prediction and guiding biologic therapies.
Area of Science:
- Pulmonary Medicine
- Immunology
- Biomarker Discovery
Background:
- Asthma research prioritizes biomarkers for phenotyping, risk stratification, and treatment guidance.
- Understanding inflammatory pathways is crucial for effective asthma management.
Purpose of the Study:
- To analyze current and emerging biomarkers for asthma.
- Focus on developments within the past two years.
Main Methods:
- Review of recent scientific literature on asthma biomarkers.
- Analysis of clinical utility and research findings.
Main Results:
- Type 2 inflammation biomarkers (blood eosinophils, FeNO) show promise for predicting exacerbations and guiding anti-IL-5/IL-4/-13 therapies.
- Urinary eicosanoids correlate with type 2 inflammation; periostin and DPP-4 trials yielded mixed results.
- Non-type 2 inflammation markers (neutrophils, YKL-40, volatile organic compounds) are under investigation.
Conclusions:
- A definitive biomarker panel for all asthma types is still evolving.
- Potential biomarkers exist, especially for non-type 2 asthma, but further research is needed.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

